128 related articles for article (PubMed ID: 12036372)
1. Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits.
Lampe JW; Biggers CK; Defauw JM; Foglesong RJ; Hall SE; Heerding JM; Hollinshead SP; Hu H; Hughes PF; Jagdmann GE; Johnson MG; Lai YS; Lowden CT; Lynch MP; Mendoza JS; Murphy MM; Wilson JW; Ballas LM; Carter K; Darges JW; Davis JE; Hubbard FR; Stamper ML
J Med Chem; 2002 Jun; 45(12):2624-43. PubMed ID: 12036372
[TBL] [Abstract][Full Text] [Related]
2. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of the benzophenone fragment of balanol via an intramolecular cyclization event.
Denieul MP; Laursen B; Hazell R; Skrydstrup T
J Org Chem; 2000 Sep; 65(19):6052-60. PubMed ID: 10987939
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
[TBL] [Abstract][Full Text] [Related]
5. An organoiron approach to the benzophenone appendage of the protein kinase C inhibitor balanol.
Storm JP; Andersson CM
Org Lett; 1999 Nov; 1(9):1451-3. PubMed ID: 10825993
[TBL] [Abstract][Full Text] [Related]
6. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
[TBL] [Abstract][Full Text] [Related]
7. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases.
Hardianto A; Yusuf M; Liu F; Ranganathan S
BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286
[TBL] [Abstract][Full Text] [Related]
8. Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners.
Gustafsson AB; Brunton LL
Mol Pharmacol; 1999 Aug; 56(2):377-82. PubMed ID: 10419557
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis of (-)-balanol, all stereoisomers, their N-tosyl analogues, and fully protected ophiocordin: an easy route to hexahydroazepine cores from garner aldehydes.
Srivastava AK; Panda G
Chemistry; 2008; 14(15):4675-88. PubMed ID: 18399526
[TBL] [Abstract][Full Text] [Related]
11. An asymmetric aminohydroxylation approach to the azepine core of (-)-balanol.
Masse CE; Morgan AJ; Panek JS
Org Lett; 2000 Aug; 2(17):2571-3. PubMed ID: 10990399
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric synthesis of the balanol heterocycle via a palladium-mediated epimerization and olefin metathesis.
Cook GR; Shanker PS; Peterson SL
Org Lett; 1999 Aug; 1(4):615-7. PubMed ID: 10823189
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and protein kinase C inhibitory activities of balanol analogues with modification of 4-hydroxybenzamido moiety.
Hu H; Mendoza JS; Lowden CT; Ballas LM; Janzen WP
Bioorg Med Chem; 1997 Sep; 5(9):1873-82. PubMed ID: 9354244
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Account on the Synthesis of (-)-Balanol and its Analogues.
Ahmad S; Akhtar R; Zahoor AF
Curr Org Synth; 2022; 19(1):56-85. PubMed ID: 34370642
[TBL] [Abstract][Full Text] [Related]
15. The Protein kinase inhibitor balanol: structure-activity relationships and structure-based computational studies.
Pande V; Ramos MJ; Gago F
Anticancer Agents Med Chem; 2008 Aug; 8(6):638-45. PubMed ID: 18690827
[TBL] [Abstract][Full Text] [Related]
16. Diverse dynamics features of novel protein kinase C (PKC) isozymes determine the selectivity of a fluorinated balanol analogue for PKCε.
Hardianto A; Khanna V; Liu F; Ranganathan S
BMC Bioinformatics; 2019 Feb; 19(Suppl 13):342. PubMed ID: 30717648
[TBL] [Abstract][Full Text] [Related]
17. Formal total synthesis of (-)-balanol: concise approach to the hexahydroazepine segment based on RCM.
Fürstner A; Thiel OR
J Org Chem; 2000 Mar; 65(6):1738-42. PubMed ID: 10750493
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of PKA-balanol interactions.
Wong CF; Hünenberger PH; Akamine P; Narayana N; Diller T; McCammon JA; Taylor S; Xuong NH
J Med Chem; 2001 May; 44(10):1530-9. PubMed ID: 11334563
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily.
Setyawan J; Koide K; Diller TC; Bunnage ME; Taylor SS; Nicolaou KC; Brunton LL
Mol Pharmacol; 1999 Aug; 56(2):370-6. PubMed ID: 10419556
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton.
Liu C; Jin J; Chen L; Zhou J; Chen X; Fu D; Song H; Xu B
Bioorg Med Chem; 2012 May; 20(9):2992-9. PubMed ID: 22459212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
